Tubular breast carcinoma: An argument against treatment de-escalation

Journal of Medical Imaging and Radiation Oncology

Volumn 56, Issue 1, 2012, Pages 116-122

  Hansen, Carmen J ^a   Kenny, Liz ^a   Lakhani, Sunil R ^b   Ung, Owen ^a   Keller, Jacqui ^a   Tripcony, Lee ^a   Cheuk, Robyn ^a   Grogan, Michelle ^a   Vargas, Ana Cristina ^b   Martin, Jarad ^a,c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Radiation Oncology Queensland   (Australia)

Author keywords

adenocarcinoma; breast neoplasm; radiotherapy; radiotherapy, adjuvant; sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TUBULAR BREAST CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84863155730     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2011.02330.x     Document Type: Review

References (27)

1. Fisher B, Anderson S, Bryant J, et al,. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41. (Pubitemid 35176242)
2. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.
3. Deos P, Usaf M, Norris H,. Well-differentiated (tubular) carcinoma of the breast. A clinicopathologic study of 145 pure and mixed cases. Am J Clin Pathol 1982; 78: 1-7. (Pubitemid 12093111)
4. McDivitt R, Boyce W, Gersell D,. Tubular carcinoma of the breast. Clinical and pathological observations concerning 135 cases. Am J Surg Pathol 1982; 6: 401-11. (Pubitemid 12044738)
5. Carstens P, Greenberg R, Francis D, et al,. Tubular carcinoma of the breast. A long-term follow-up. Histopathology 1985; 9: 271-80. (Pubitemid 15146904)
6. Cabral A, Recine M, Paramo M, et al,. Tubular carcinoma of the breast: an institutional experience and review of the literature. Breast J 2003; 9: 298-301. (Pubitemid 36927410)
7. Diab S, Clark G, Osborne C, et al,. Tumour characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 1999; 17: 1442-8. (Pubitemid 29220850)
8. Rakha E, Lee A, Evans A, et al,. Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol 2010; 28: 99-104.
9. Kempson R,. Stanford school of medicine surgical pathology criteria: tubular carcinoma of the breast. 2008. [Cited 17 June 2010.] Available from URL
10. Livi L, Paiar F, Meldolesi E, et al,. Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. Eur J Surg Oncol 2005; 31: 9-12. (Pubitemid 40103918)
11. Liu G, Yang Q, Haffty B, et al,. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. Int J Radiat Oncol Biol Phys 2009; 75: 1304-8.
12. Sullivan T, Abi Raad R, Goldberg S, et al,. Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat 2005; 93: 199-205. (Pubitemid 41441289)
13. Kader H, Jackson J, Mates D, et al,. Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and patterns of relapse. Breast J 2001; 7: 8-13. (Pubitemid 32162841)
14. Oberman H, Fidler W,. Tubular carcinoma of the breast. Am J Surg Pathol 1979; 13: 387-95. (Pubitemid 10241471)
15. Holland DW, Boucher LD, Mortimer JE, et al,. Tubular breast cancer experience at Washington University: a review of the literature. Clin Breast Cancer 2001; 2: 210-4. (Pubitemid 33085767)
16. Javid S, Smith B, Mayer E, et al,. Tubular carcinoma of the breast: results of a large contemporary series. Am J Surg 2008; 197: 674-7.
17. Fisher B, Bryant J, Dignam D, et al,. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumour recurrence after lumpectomy in women with invasive breast cancers of one centimetre or less. J Clin Oncol 2002; 20: 4141-59.
18. Fisher E, Constantino J, Leon M, et al,. Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0). Cancer 2007; 110: 1929-36.
19. Thurman S, Schnitt S, Connolly J, et al,. Outcome after breast-conserving therapy for patients with stage i or ii mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys 2004; 59: 152-9. (Pubitemid 38501519)
20. Peters G, Wolff M, Haagensen C, et al,. Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases. Ann Surg 1981; 193: 138-49. (Pubitemid 11153094)
21. Cserni G,. Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma. J Clin Pathol 2002; 55: 293-7. (Pubitemid 34293398)
22. Goldstein N, Kestin L, Vicini F,. Refined morphologic criteria for tubular carcinoma to retain its favourable outcome status in contemporary breast carcinoma patients. Am J Clin Pathol 2004; 122: 728-39. (Pubitemid 39434754)
23. Romestaing P, Lehingue Y, Carrie C, et al,. Role of a 10Gy boost in the conservative treatment of early breast cancer: results of a randomised trial. J Clin Oncol 1991; 15: 963-8.
24. Bartelink J, Horiot J, Poortsmans P, et al,. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 245: 1378-87.
25. Bartelink H, Horiot J, Poortmans P, et al,. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25: 3259-65. (Pubitemid 47325610)
26. Gill G, The SNAC Trial Group (Writing Committee-Gill GP (chair), Wetzig N, Gebski V, Stockler M, Ung O, Campbell I, Simes J). Sentinel-lymph-node-based management or routine axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 2009; 16: 266-75.
27. Winchester D, Sahin A, Tucker S, et al,. Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence. Ann Surg 1996; 223: 342-7. (Pubitemid 26086726)